NCT07634289
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07634289
Title Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma (Radio-GLO)
Acronym Radio-GLO
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Olivia Newton-John Cancer Research Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Townsville University Hospital Douglas Queensland Australia Details
Princess Alexandra Hospital Woolloongabba Queensland 4102 Australia Details
Flinders Medical Centre Bedford Park South Australia 5042 Australia Details
Austin Hospital Heidelberg Victoria 3084 Australia Details
Fiona Stanley Hospital Murdoch Western Australia Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field